Pacliget 30mg Injection

About

Paclitaxel is an antineoplastic agent belonging to the taxane class, widely used in cancer chemotherapy for various solid tumors. Its primary mechanism of action involves promoting the assembly of microtubules from tubulin dimers and stabilizing them by preventing depolymerization. This leads to the inhibition of normal dynamic reorganization of the microtubule network, which is essential for vital interphase and mitotic cellular functions, including cell division. Consequently, cells are arrested in the G2/M phase of the cell cycle, leading to apoptosis and inhibition of tumor growth. Administered intravenously, it is a crucial component in the treatment regimens for cancers such as ovarian, breast, and non-small cell lung cancer, often used alone or in combination with other cytotoxic agents.

Uses

• Treatment of ovarian cancer.
• Management of breast cancer.
• Therapy for non-small cell lung cancer.
• Treatment of Kaposi's sarcoma in AIDS patients.

Directions For Use

Administer intravenously under the supervision of a qualified oncologist. Dosage and infusion schedule are determined by the specific cancer type and patient's condition.

Benefits

• Effective against a broad spectrum of solid tumors.
• Induces tumor regression and controls disease progression.
• Can be used in combination with other chemotherapies.
• Improves survival rates in certain cancers.
• Well-established efficacy profile.
• Offers a treatment option for advanced cancers.

Side Effects

• Myelosuppression (neutropenia, thrombocytopenia, anemia)
• Peripheral neuropathy
• Hypersensitivity reactions
• Alopecia (hair loss)
• Nausea and vomiting
• Diarrhea
• Muscle and joint pain (arthralgia/myalgia)
• Fatigue
• Mucositis
• Bradycardia
• Hypotension
• Injection site reactions

Safety Measures

• Alcohol - Alcohol should be avoided during chemotherapy as it can exacerbate side effects like nausea, fatigue, and liver strain, and may interact with other medications.
• Pregnancy - Contraindicated in pregnancy due to significant risk of fetal harm. Women of childbearing potential must use effective contraception.
• Breastfeeding - Breastfeeding is contraindicated during paclitaxel therapy and for a period after, due to the potential for serious adverse reactions in the infant.
• Liver - Dose adjustments are necessary in patients with liver impairment. Use with extreme caution and monitor liver function closely.
• Kidney - No specific dose adjustment is generally required for mild to moderate renal impairment, but caution is advised.
• Lung - Rare but serious pulmonary toxicity, including interstitial pneumonia, has been reported. Monitor for respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.